International Society for Cellular Therapy 2018 - Triumvira Immunologics | Engineered T Cell Therapies

Triumvira will be presenting at ISCT 2018 – May 2-5, 2018 at the Palais des Congrès de Montréal in Montréal, QC, Canada

ISCT is the premier cell therapy translation society focused on pre-clinical, clinical and translational aspects of developing cell therapy products. As such, ISCT helps academic, government and biotech/pharma sectors transform research into practice and product.

ISCT 2018 is expected to draw over 1,600 delegates globally. The Annual Meeting will serve as the prime opportunity for you to network with experts within the global cell therapy arena.

Learn more and register here

[Triumvira Immunologics Announc ..](/content/triumvira-immunologics-announces-strategic-relationship-for-gmp-manufacturing-with-centre-for-commercialisation-of-cancer-immunotherapy/ "Triumvira Immunologics Announces Strategic Relationship for GMP Manufacturing with Centre for Commercialisation of Cancer Immunotherapy"/index.html) [Triumvira Immunologics to Pres ..](/content/triumvira-immunologics-to-present-at-two-upcoming-conferences-international-society-for-cellular-therapy-and-bloom-burton-co-healthcare-investor-conference/ "Triumvira Immunologics to Present at Two Upcoming Conferences:"/index.html)